chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Also he seems not to hear completely well; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An adult male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOACUSIS (non-serious), outcome "unknown", described as "Also he seems not to hear completely well". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient was near syncope. After receiving the vaccine about 2 minutes she started getting light headed. Patient was given water and animal crackers to get. She was feeling a little better but when she turned her head she still felt lightheaded. I had her eat and drink some more water. I asked how she was feeling. She stated that she was feeling better so i had her sit the rest of the way up with her feet hanging over the bed. I asked how she was feeling. She stated that she was feeling good. I then had her stand up with me standing in front of her and asked how she was feeling. She stated that she was feeling light headed in the middle of her forehead. I had her sit back down and gave her an ice pack to put on her neck. I then asked how she was feeling and she stated that she was feeling better and while she had the ice pack on her forehead she kept eating and drinking. I then had her stand up and she stated that she was better. i took her vitals at 11:24 am heart rate 75, o2 99 and BP 115/81, again at 11:30 am heart rate 79, o2 97 and BP 117/82. I released her to go home with her mom and dad at 11:41.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown age and gender. The patient's current conditions and medical history were not provided by the reporter. On an unknown date, the patients were vaccinated with multiple doses of improperly stored GARDASIL 9 (strength, dose, route of administration,lot/batch# and expiration date were not reported) for prophylaxis.The temperature and time frame to which vaccine was exposed was unknown by the reporter. There was no previous temperature excursion. No adverse events were reported. Digital data logger was involved. It was reported that there were multiple lots involved. There was no product quality complaint(PQC) involved. It was requested to send copies of data logger information as opposed to multiple excursion forms. This is one of the several reports received from same reporter. Sender's Comments: US-009507513-1708USA003015: US-009507513-1708USA003605: US-009507513-1708USA003606: US-009507513-1708USA003607: US-009507513-1708USA003604.
Got the vaccine and within 24 hours she developed generalized achiness but more so in the right arm, opposite where she received the vaccine.  Then, after 24 hours she developed a low grade fever and achiness and malaise which lasted about 36 hours.  After she slept that off she has had no more issues.   She took extra strength Tylenol for the fever and achiness which did help.  She did not notify her doctor.
Information has been received from a physician refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a of improperly stored dose of one of the following vaccines: ROTATEQ (lot number and expiration date not reported), LIQUID PEDVAXHIB (lot number N000238 and expiration date 25-OCT-2019), RECOMBIVAX HB (Lot number N011851 and expiration date 19-DEC-2019) and VAQTA (Lot number reported as M005796 and expiration date 26-MAY-2018)  (route of administration was not reported) for prophylaxis, which were stored in the range of 47 Fahrenheit degrees to 77 Fahrenheit degrees for 2 hours and 30 minutes. No previous temperature excursion was reported. No adverse effects were reported. Digital data logger was involved. Lot number M005796 is an invalid lot number for hepatitis a vaccine, inactivated.
UrticariaPruritus soreness at the injection site, developed axilla lymphadenopathy, swelling and itching at site Narrative:
Myalgia, Arthralgia, Fever, The employee experienced headache, sore at injection site, fever (low grade). chills and body aches within 12 hours after receiving second dose. Narrative:
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included Flu unspecified (Influenza vaccine). On 17th September 2018 02:30, the patient received the 1st dose of SHINGRIX (intramuscular). On 17th September 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm, fatigue, general body pain, headache, shivering, feeling cold and influenza like illness. On an unknown date, the outcome of the pain in arm, fatigue, general body pain, headache, shivering, feeling cold and influenza like illness were recovered/resolved. It was unknown if the reporter considered the pain in arm, fatigue, general body pain, headache, shivering, feeling cold and influenza like illness to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in left arm. The patient was also given a flu shot at the same time that day. The patient experienced a sore arm after receiving the injection. A headache followed soon after. A couple of hours later, she felt chills, body aches and fatigue. The patient spent the next 24 hours in bed. All symptoms lasted approximately 24 hours. Less than a day after receiving SHINGRIX, the patient described it as feeling like she had the flu. The patient was very cold when she went to bed and had to put socks on and blankets.
Patient claims to have been in perfect health prior.  pt had complete physical on 08/09/2019 - pt was offered shingrix and has been sick ever since - pt was hospitalized one week after immunization (quarantined).  Pt was discharged 6 days later, still not feeling better.  Patient has active sores all over both arms, shoulders, back, and legs.  Pt claim this is eating him away and stealing his energy to death.
WITHIN 5 minutes of BoTh vaceinations ,  patient fainteD  to flooR.  RegaineD consciousness  after   a Few seconds (approx). patient  states  she   Doesn't think  she  hit any- thing on way Down DenieD amBulance , was proviDED wateR.
Approximately 45 minutes after the injection, I developed a little tongue itching and a single hive on my tongue, but it resolved and I was fine. I was fine until later that evening (Friday Sept 3) at about 11PM when I had a syncopal episode- I felt very lightheaded and I suspect my bp dropped. I had an itchy rash that extended down the (left) arm in which I received the vaccine. This was followed by bouts of severe vomiting until about 4AM, as well as severe headache, fever and chills. I am a board-certified allergist and I would consider this a delayed anaphylactic reaction.
Child screaming very hard to calm after. Shot turned into a red mark that scarred and never went away. Child was 100% breastfed. Vaccines are not needed when mother's antibodies transfers to a newborn. This same child went on to later have more severe vaccine reactions that could have ultimately been prevented.
VARlVAX was given to a patient after the temperature excursion occurred; no AE; This spontaneous report was received from an office manager and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent condition, concomitant medication and medical history provided.  On 13-JUL-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot: T032315, expiration date: 22-SEP-2022, for prophylaxis, 1 time dose (exact dose and route of administration were not provided).  The varicella virus vaccine live (oka/merck)(VARIVAX) experienced temperature excursion of -9.3 degree Celsius for 42 minutes. Previous temperature excursion was not detected. The digital data logger was involved.
Left deltoid muscle pain for 2 days following vaccination and then radiated to left shoulder joint unrelieved w/VICODIN/ibuprofen 500 mg. Pt reports numbness/tingling radiating to palm of left hand - feels heavy & burning sensation.
This spontaneous report was received from a Registered Nurse refers to 7 unspecified patients of unknown age and gender. The nurse reported that between 27-AUG-2013 and 06-SEP-2013, the patients received unspecified doses (in schedule) of GARDASIL (lot # H021861,expiry:09-OCT-2015) 0.5 ml, intramuscularly. Nurse stated that the GARDASIL doses were exposed to 31F maximum for total of 1.5 hours cumulatively on 27-AUG-2013. No adverse effects reported. Follow up information has been received from the registered nurse, who stated that after reviewing office records, 4 patients (previously reported as 7 patients) had received the vaccinations. The patient identifiers were given and dates of birth. The patient concerning his report was currently 14 years old. This case is related with MARRS 1309USA003768, 1309USA012207, 1309USA012209. Additional information has been requested.
Patient c/o headache, tinnitus, and "not feeling well" x24 hrs after vaccine.
Initial misuse report received from a healthcare professional on 28 June 2013. It was reported that reconstituted YF-VAX, lot no. UH666AA, drew up into syringe, and while recapping needle stuck self with needle. No information was provided regarding the patients. No adverse event was reported. Documents held by sender: none.
No further AE reported; Caller is reporting a temperature excursion for vaccines that have been administered; This spontaneous report has been received from an office manager concerning an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, historical drugs, medical history and concomitant therapies were not reported.       On 21-OCT-2020, the patients were vaccinated with the following vaccines that underwent a temperature excursion: - Rotavirus vaccine, live, oral, pentavalent(ROTATEQ) 0.5 ml, Lot # 1684153, expiration date 23-JUN-2021  for prophylaxis.   - Hepatitis a vaccine, inactivated(VAQTA) formulation not reported but upon internal validation stablished as vial,  0.5 ml, Lot # T018227, expiration date 11-DEC-2021 for prophylaxis.   The temperature was reported to had been below36°F, more specifically at 33.8 °F for 30 minutes.  No further adverse event (AE) was reported.  There was digital data logger involved and  no previous temperature excursion was reported.   This is a non valid case due to lack of patients' identifiers.
Low grade fever horrible headaches fatigue chills, body aches, listlessness, uneasy. Highest fever 100.1. 2 extra strength Tylenol and 4 ibuprofens. My oxygen low about 82 on that Sunday AM on my oximeter. My body went into an immune response. I felt horrible and I thought that it was the end. These headaches do not stop on a weekly basis almost 4- 5 days a week. Covid in 19 Jan 2021 took 3 weeks. Got anti bodies infusion and supposed to wait 90 days. These days and should be more. I think I have long haul Covid syndrome.
Localized erythema at injection site, as well as tricep region significant pain / no fever or generalized myalgia.
pt recv vax 11DEC95 & 27DEC95 pt exp inc bilirubin;no further details were provided;
Lymph node swelling; Lymph node swelling and infection three times; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Feb2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 16Feb2021, the patient experienced lymph node swelling and infection three times. The events lymph node swelling and infection resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with unspecified antibiotics. The clinical outcome of the events lymph node swelling and infection was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
10/28/05 Lt thigh with 3cmX1 3/4 red indurated, warm with central injection site: + ?? + range ??.
Sharp, Stabbing Chest Pain, Breast Pain, Back Pain, Fatigue,  Loss of Appetite  Treatment: ER visit 5/12/21 resulting in discovery and diagnosis of Pericarditis and Pericardial Effusion
shingrix vaccines with the adjuvant only; shingrix vaccines with the adjuvant only; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. A healthcare provider at the doctor's office gave Shingrix vaccine with the adjuvant only which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  They took inventory the day before the day of reporting and had Shingrix antigens was left.  They were not sure which patients received full dose and which patients received the adjuvant only. They stated that, all the patients that received Shingrix during this week would have to get revaccinated.  The doctor's office reported this to CDC.  No other information was available.  This was 1 of 5 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021177375:same reporter, shingrix US-GLAXOSMITHKLINE-US2021AMR178137:same reporter, shingrix US-GLAXOSMITHKLINE-US2021AMR178146:same reporte
Narrative: referred to hematology for newly diagnosed RUE brachial vein DVT (4/9/21) in the setting of recent COVID vaccination (3/5/21). He reported RUE swelling and Doppler report revealed acute mid-right brachial vein thrombus. Per H/O, it is likely that the current DVT IS provoked in the setting of immobility and possibly recent COVID vaccination.
Received TC from pts mother on 07/19/2006 at 3:30 pm. States pts right arm swollen. Instructed to apply cold compresses and take to ER and to call 911 it has problems breathing.
Lethargic; sore at the injection site; fever; shivering; cold sweats; hot flashes; body aches; headache; This is a spontaneous report from a contactable consumer (patient). A 26-year-old female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (COMIRNATY, PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection and batch no: not reported/lot number: EL3247), via an unspecified route of administration, administered in Left arm on 19Feb2021 10:30 (at the age of 26-year-old) as dose 2, single for covid-19 immunization at workplace clinic. Medical history included fibromyalgia. Concomitant medications included fish oil and gabapentin, via an unspecified route at an unknown dose from an unknown date for unspecified indication. Historical vaccine included as patient received her first dose of bnt162b2 (COMIRNATY, PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection, batch no: not reported/lot number: EL3247) via an unspecified route of administration, in left arm on 29Jan2021 10:30 AM (at the age of 25-year-old) as dose 1, single for covid-19 immunization. The patient had not received any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19 and since the vaccination. On 19Feb2021 at 11:00 PM, patient reported that she was lethargic and sore at the injection site several hours after the vaccination. After 12 hours symptoms included fever, shivering, cold sweats, hot flashes, body aches, headache. Symptoms persisted for 32 hours. Headache remained up to 60 hours after the vaccine was administered. The outcome of the events was recovered on an unknown date in Feb2021.  No follow-up attempts are possible. No further information is expected.
Chills, body aches, temperature of 100.5 headache.16 hrs after injection.  Took Tylenol
MOTHER NOTICED AREAS WHERE VACCINES WERE GIVEN WERE RED, SWOLLEN AND INFLAMED. PARENT CALLED NURSE ADVICE LINE AND WAS TOLD TO TAKE CHILD TO AN URGENT CARE CENTER FOR EVALUATION. MOTHER RETURNS CALL TODAY TO GIVE UPDATE ON PATIENT'S CONDITION. AREAS ON BOTH LEGS ARE DIMINISHED IN SIZE. THERE IS STILL A QUARTER SIZED AREA ON PATIENT'S LEFT THIGH WHERE THE PROQUAD WAS GIVEN. MOTHER IS USING BENADRYL, ZYRTEC, AND CALAMINE LOTION TO AFFECTED AREAS.
Bivalent Pfizer 6mo-4yr vaccine given as dose #1 instead of the monovalent vaccine
In around July of 2022, my eyes started watering. It got steadily worse, until I called the doctor. He told me I have dry eyes. I started using over the counter eye drops and it didn't get better. I went back to the doctor, and he prescribed Restasis. It hasn't fixed it by any means, but it is better than it was. I feel less need to use the lubricant eye drops. I am still taking the Restasis.
GAVE PATIENT A FULL 0.5 ML DOSE OF MODERNA INSTEAD OF 0.25 ML PER CDC GUIDELINES FOR PATIENTS WHO ARE IMMUNOCOMPROMISED.  PATIENT AND PATIENT'S DOCTOR REQUESTED THE 0.5 ML DOSE. NO CURRENT SIDE EFFECTS.
This case was reported by a consumer (also the subject) and described the occurrence of shooting pain up the neck in a 18-year-old female subject who was vaccinated with HEPATITIS A vaccine (manufacturer unspecified).  A physician or other health care professional has not verified this report.  Co-suspect medication included Cyanocobalamin (Vitamin B 12).  On 6 May 2008 at 13:15 the subject received 2nd dose of HEPATITIS A vaccine in the left arm.  During the injection with HEPATITIS A vaccine, the subject experienced a shooting pain up her neck that lasted for a little while after the injection, but resolved the same day.  The subject experienced a systemic reaction.  The reporter was concerned about the red coloring of the injectable.  This was considered to be a product complaint.  At the time of reporting the outcome of the events was unspecified.  Additional information provided on 09 May 2008 indicated that the injection that was red in color may have actually been the vitamin B12 injection and not the HEPATITIS A injection.  The events may have been in response to the vitamin B12 injection.  Follow-up information was received on 28 MAY 2008 via a consumer (also the subject), who reported that she now realizes that the shooting pain she experienced was due to a Vitamin B 12 injection, not the HEPATITIS A vaccine.  The consumer/subject stated that she was able to identify the injection which caused the pain by the color of the vaccine.  The subject indicated that she did not contact her physician about the event, and did not provide any physician contact information.
Underage patient was administered a full dose of the Pfizer COVID-19 in error. Patient did not report any adverse affect from the dose given. We have continued to follow up to make sure he is still doing ok.
8:00 p.m. symptoms came on suddenly; sore arm (still sore - three days now) low grade fever(two days) uncontrollable shivers body aches headache (two days) fatigue (two days) heart racing
I have had problems with my breathing; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 42-years-old female patient received second dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported) via an unspecified route of administration on Apr2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 on Mar2021 for covid-19 immunization. It was reported that patient received shot back in March then April since then she had problems with her breathing. Patient wanted to know what is going on. Therapeutic measures were taken as a result of i had problems with my breathing with inhalers and prednisone. The outcome for the event was reported as unknown at the time of this report.   Information about lot/batch number has been requested.
"Pt stated got Pfizer COVID-19 vaccine 1st dose. Last night HA, fatigue this AM migraine. Pt states has 75 mg and 100 mg imitrex, has not taken imitrex"
Got Shingles above the forehead, after second dose of vaccination, I am not sure if it is related to Vaccination or not. just wanted to report, in case its related to Side effects of the vaccine
Pt states she woke up on Saturday morning with severe cervical and sacral pain. Then Saturday pm pt started noticing numbness on her left side started around ribs and left arm. Then progressed to left side of her body, down her left leg and to her left foot. Pt states that on Sunday that the bottom of her right foot started to feel numb. Pt states that her feet feel extremely heavy.
Information has been received from a physician concerning a female patient who her husband on an unspecified date was vaccinated with a 0.65 ml single dose of ZOSTAVAX (Merck) (Lot#: not reported). The physician stated that after her husband received the vaccine, on an unspecified date the patient experienced shingles. At the time of the report, the patient outcome was unknown. The patient sought unspecified medical attention. Follow up information has been received from the physician who reported that a 73 year old male patient of his with hypertension, cardiac artery disease and sleep apnea went to the local clinic and received a dose of ZOSTAVAX (Merck). The physician did not know the lot number or type of vaccination. After the vaccination that night while going to sleep he sneezed in his 68 year old wife's face. One week after the incident, his wife was diagnosed with herpes zoster at a local urgent care. The physician did not know if the wife's herpes zoster was related to her husband's vaccination or sneezing. The physician also reported that the wife's medical condition included osteoarthritis, gastrooesophageal reflux disease and hypertension. At the time of the report, the outcome was unknown. Additional information has been requested.